Most Cited & Viewed
Most Cited & Viewed Papers
Citations | Article |
---|---|
Views | Article |
---|---|
Downloads | Article |
---|---|
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Citations | Article |
---|---|
Decoding the Oncogenic Signals from the Long Non-Coding RNAs
by
Revathy Nadhan and Danny N. Dhanasekaran
|
|
ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma
by
Fatih M. Uckun and Sanjive Qazi
|
|
Tumor Cell Secretomes in Response to Anti- and Pro-Tumorigenic Agents
by
Sheng-Zhi Liu, Xun Sun, Ke-Xin Li, Chien-Chi Lin, Sungsoo Na, Bai-Yan Li and Hiroki Yokota
|
|
Optimizing the Pharmacological and Optical Dosimetry for Photodynamic Therapy with Methylene Blue and Nanoliposomal Benzoporphyrin on Pancreatic Cancer Spheroids
by
Tristan Le Clainche, Nazareth Milagros Carigga Gutierrez, Núria Pujol-Solé, Jean-Luc Coll and Mans Broekgaarden
|
|
Role of NK Cells in Cancer and Immunotherapy
by
Paresh Vishwasrao, Susanta K. Hui, D. Lynne Smith and Vishal Khairnar
|
|
Akt/mTOR Activation in Lung Cancer Tumorigenic Regulators and Their Potential Value as Biomarkers
by
Carolina Sousa, Beatriz Silva-Lima and Mafalda Videira
|
|
Fucoxanthinol Promotes Apoptosis in MCF-7 and MDA-MB-231 Cells by Attenuating Laminins–Integrins Axis
by
Ayaka Yasuda, Momoka Wagatsuma, Wataru Murase, Atsuhito Kubota, Hiroyuki Kojima, Tohru Ohta, Junichi Hamada, Hayato Maeda and Masaru Terasaki
|
|
Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma
by
Brady Anderson, Mary Vue, Nya Gayluak, Sarah Jane Brown, Lynne T. Bemis and Glenn E. Simmons, Jr.
|
|
Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer
by
Gee Young Lee, Mohamed Mubasher, Tamra S. McKenzie, Nicole C. Schmitt, Merry E. Sebelik, Carrie E. Flanagan, Badi El Osta, Maya B. Cothran and Hadiyah-Nicole Green
|
Citations | Article |
---|---|
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
by
Sagarajit Mohanty
|
|
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
by
Poojarani Panda, Henu Kumar Verma and Lakkakula V. K. S. Bhaskar
|
|
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
by
Fnu Amisha, Paras Malik, Prachi Saluja, Nitesh Gautam, Tanvi Harishbhai Patel, Arya Mariam Roy, Sunny R. K. Singh and Sindhu Janarthanam Malapati
|
Citations | Article |
---|---|
No cited articles available for this period. |
Views | Article |
---|---|
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
by
Sagarajit Mohanty
|
|
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
by
Fnu Amisha, Paras Malik, Prachi Saluja, Nitesh Gautam, Tanvi Harishbhai Patel, Arya Mariam Roy, Sunny R. K. Singh and Sindhu Janarthanam Malapati
|
|
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
by
Poojarani Panda, Henu Kumar Verma and Lakkakula V. K. S. Bhaskar
|
|
Anticancer Effects of Fucoxanthin in a PDX Model of Advanced Stage Pancreatic Cancer with Alteration of Several Multifunctional Molecules
by
Masaru Terasaki, Sally Suzuki, Takuji Tanaka, Hayato Maeda, Masaki Shibata, Kazuo Miyashita, Yasuhiro Kuramitsu, Junichi Hamada, Tohru Ohta, Shigehiro Yagishita, Akinobu Hamada, Yasunari Sakamoto, Susumu Hijioka, Chigusa Morizane and Mami Takahashi
|
|
ROS1-Rearranged Lung Adenocarcinoma: From Molecular Genetics to Target Therapy
by
Ugo Testa, Germana Castelli and Elvira Pelosi
|
|
Machine Learning-Based Model Helps to Decide which Patients May Benefit from Pancreatoduodenectomy
by
Emanuel Vigia, Luís Ramalhete, Edite Filipe, Luís Bicho, Ana Nobre, Paulo Mira, Maria Macedo, Catarina Aguiar, Sofia Corado, Beatriz Chumbinho, Jorge Balaia, Pedro Custódio, João Gonçalves and Hugo P. Marques
|
|
Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients
by
Constantin N. Baxevanis, Savvas Stokidis, Maria Goulielmaki, Angelos D. Gritzapis and Sotirios P. Fortis
|
|
Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis
by
Arya Mariam Roy, Supritha Chintamaneni, Sabah Alaklabi, Hassan Awada, Kristopher Attwood and Shipra Gandhi
|
|
Onco: A Promising Player Amidst Oncology Journals
by
Constantin N. Baxevanis
|
Views | Article |
---|---|
Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis
by
Arya Mariam Roy, Supritha Chintamaneni, Sabah Alaklabi, Hassan Awada, Kristopher Attwood and Shipra Gandhi
|
|
When Therapy-Induced Cancer Cell Apoptosis Fuels Tumor Relapse
by
Razmik Mirzayans
|
|
Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by
Jiřina Bartůňková
|
|
Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress
by
Philippa Lantwin, Adam Kaczorowski, Cathleen Nientiedt, Constantin Schwab, Martina Kirchner, Viktoria Schütz, Magdalena Görtz, Markus Hohenfellner, Anette Duensing, Albrecht Stenzinger and Stefan Duensing
|
|
How Reliable Are Predictions of CD8+ T Cell Epitope Recognition? Lessons for Cancer
by
Alexander A. Lehmann, Paul V. Lehmann and Stephen Todryk
|
|
Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function
by
Shogo Maruzen, Seiichi Munesue, Mitsuyoshi Okazaki, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Linxiang Gong, Susumu Kohno, Chiaki Takahashi, Hidehiro Tajima, Yasuhiko Yamamoto and Shintaro Yagi
|
Views | Article |
---|---|
Role of NK Cells in Cancer and Immunotherapy
by
Paresh Vishwasrao, Susanta K. Hui, D. Lynne Smith and Vishal Khairnar
|
|
Akt/mTOR Activation in Lung Cancer Tumorigenic Regulators and Their Potential Value as Biomarkers
by
Carolina Sousa, Beatriz Silva-Lima and Mafalda Videira
|
|
The Impact of Immune Checkpoint-Inhibitors Therapy in Urinary Bladder Cancer
by
Ana Lúcia Silva, Pedro Abreu-Mendes, Diana Martins and Fernando Mendes
|
|
Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review
by
Ben Johnson, Kenneth Lee and Yuen Yee Cheng
|
|
Targeting HMGB1 in the Treatment of Non-Small Cell Lung Adenocarcinoma
by
Brady Anderson, Mary Vue, Nya Gayluak, Sarah Jane Brown, Lynne T. Bemis and Glenn E. Simmons, Jr.
|
|
Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma
by
Daniel Zeitouni, Michael P. Catalino, Jordan Wise, Sean McCabe, Kathryn Pietrosimone, Naim Rashid and Simon Khagi
|
|
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
by
Sagarajit Mohanty
|
|
Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives
by
Luca Filippi, Viviana Frantellizzi, Marko Magdi Abdou Sidrak, Joana Gorica, Stefano Scippa, Agostino Chiaravalloti, Orazio Schillaci, Oreste Bagni and Giuseppe De Vincentis
|
|
Decoding the Oncogenic Signals from the Long Non-Coding RNAs
by
Revathy Nadhan and Danny N. Dhanasekaran
|
Downloads | Article |
---|---|
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
by
Sagarajit Mohanty
|
|
Anticancer Effects of Fucoxanthin in a PDX Model of Advanced Stage Pancreatic Cancer with Alteration of Several Multifunctional Molecules
by
Masaru Terasaki, Sally Suzuki, Takuji Tanaka, Hayato Maeda, Masaki Shibata, Kazuo Miyashita, Yasuhiro Kuramitsu, Junichi Hamada, Tohru Ohta, Shigehiro Yagishita, Akinobu Hamada, Yasunari Sakamoto, Susumu Hijioka, Chigusa Morizane and Mami Takahashi
|
|
A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
by
Fnu Amisha, Paras Malik, Prachi Saluja, Nitesh Gautam, Tanvi Harishbhai Patel, Arya Mariam Roy, Sunny R. K. Singh and Sindhu Janarthanam Malapati
|
|
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
by
Poojarani Panda, Henu Kumar Verma and Lakkakula V. K. S. Bhaskar
|
|
ROS1-Rearranged Lung Adenocarcinoma: From Molecular Genetics to Target Therapy
by
Ugo Testa, Germana Castelli and Elvira Pelosi
|
|
Machine Learning-Based Model Helps to Decide which Patients May Benefit from Pancreatoduodenectomy
by
Emanuel Vigia, Luís Ramalhete, Edite Filipe, Luís Bicho, Ana Nobre, Paulo Mira, Maria Macedo, Catarina Aguiar, Sofia Corado, Beatriz Chumbinho, Jorge Balaia, Pedro Custódio, João Gonçalves and Hugo P. Marques
|
|
Onco: A Promising Player Amidst Oncology Journals
by
Constantin N. Baxevanis
|
|
Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients
by
Constantin N. Baxevanis, Savvas Stokidis, Maria Goulielmaki, Angelos D. Gritzapis and Sotirios P. Fortis
|
|
The Organization of Contemporary Biobanks for Translational Cancer Research
by
Vasiliki Gkioka, Olga Balaoura, Maria Goulielmaki and Constantin N. Baxevanis
|
Downloads | Article |
---|---|
Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis
by
Arya Mariam Roy, Supritha Chintamaneni, Sabah Alaklabi, Hassan Awada, Kristopher Attwood and Shipra Gandhi
|
|
When Therapy-Induced Cancer Cell Apoptosis Fuels Tumor Relapse
by
Razmik Mirzayans
|
|
Dendritic Cell Immunotherapy for Ovarian Cancer: An Overview of Our Achievements
by
Jiřina Bartůňková
|
|
Deficiency in DNA Damage Repair Proteins Promotes Prostate Cancer Cell Migration through Oxidative Stress
by
Philippa Lantwin, Adam Kaczorowski, Cathleen Nientiedt, Constantin Schwab, Martina Kirchner, Viktoria Schütz, Magdalena Görtz, Markus Hohenfellner, Anette Duensing, Albrecht Stenzinger and Stefan Duensing
|
|
Inhibitory Effects of Metformin for Pancreatic Neuroendocrine Neoplasms: Experimental Study on Mitochondrial Function
by
Shogo Maruzen, Seiichi Munesue, Mitsuyoshi Okazaki, Satoshi Takada, Shinichi Nakanuma, Isamu Makino, Linxiang Gong, Susumu Kohno, Chiaki Takahashi, Hidehiro Tajima, Yasuhiko Yamamoto and Shintaro Yagi
|
|
How Reliable Are Predictions of CD8+ T Cell Epitope Recognition? Lessons for Cancer
by
Alexander A. Lehmann, Paul V. Lehmann and Stephen Todryk
|